Publicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (20)

2023

  1. Contribution of Telomere Length to Systemic Sclerosis Onset: A Mendelian Randomization Study

    International Journal of Molecular Sciences, Vol. 24, Núm. 21

  2. External clinical validation of automated software to identify structural abnormalities and microhaemorrhages in nailfold videocapillaroscopy images

    Clinical and experimental rheumatology, Vol. 41, Núm. 8, pp. 1605-1611

2022

  1. Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis

    npj Genomic Medicine, Vol. 7, Núm. 1

  2. The Effect of Body Fat Distribution on Systemic Sclerosis

    Journal of Clinical Medicine, Vol. 11, Núm. 20

2021

  1. Multidisciplinary care and units for uveitis in the internal medicine departments in Spain: Survey of the Systemic Autoimmune Diseases Group

    Revista Clinica Espanola, Vol. 221, Núm. 4, pp. 221-225

  2. SARS-CoV-2 infection in patients with primary Sjögren syndrome: Characterization and outcomes of 51 patients

    Rheumatology (United Kingdom), Vol. 60, Núm. 6, pp. 2946-2957

  3. Tocilizumab in refractory Caucasian Takayasu’s arteritis: a multicenter study of 54 patients and literature review

    Therapeutic Advances in Musculoskeletal Disease, Vol. 13

2019

  1. LAUDES Study: impact of digital ulcers on hand functional limitation, work productivity and daily activities, in systemic sclerosis patients

    Rheumatology International, Vol. 39, Núm. 11, pp. 1875-1882

2018

  1. Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease

    Ophthalmology, Vol. 125, Núm. 9, pp. 1444-1451

2017

  1. An MIF promoter polymorphism is associated with susceptibility to pulmonary arterial hypertension in diffuse cutaneous systemic sclerosis

    Journal of Rheumatology, Vol. 44, Núm. 10, pp. 1453-1457

  2. Clinical and epidemiological differences between men and women with systemic sclerosis: A study in a Spanish systemic sclerosis cohort and literature review

    Clinical and Experimental Rheumatology, Vol. 35, pp. S89-S97

2016

  1. Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry

    Seminars in Arthritis and Rheumatism, Vol. 46, Núm. 2, pp. 200-208

2015

  1. Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis

    Clinical and Experimental Rheumatology, Vol. 33, pp. 31-35

  2. Registry of the Spanish network for systemic sclerosis: Survival, prognostic factors, and causes of death

    Medicine (United States), Vol. 94, Núm. 43

  3. Somatic NLRP3 mosaicism in Muckle-Wells syndrome. A genetic mechanism shared by different phenotypes of cryopyrin-associated periodic syndromes

    Annals of the Rheumatic Diseases, Vol. 74, Núm. 3, pp. 603-610

2014

  1. Health-related internet use by patients with systemic sclerosis and other autoimmune diseases: Comment on the article by van der vaart et al

    Arthritis Care and Research

2013

  1. New insight on the Xq28 association with systemic sclerosis

    Annals of the Rheumatic Diseases, Vol. 72, Núm. 12, pp. 2032-2038

2012

  1. Bone mass and vitamin D in patients with systemic sclerosis from two Spanish regions

    Clinical and Experimental Rheumatology, Vol. 30, Núm. 6, pp. 905-911

  2. Registry of the Spanish Network for Systemic Sclerosis: Clinical Pattern According to Cutaneous Subsets and Immunological Status

    Seminars in Arthritis and Rheumatism, Vol. 41, Núm. 6, pp. 789-800

2005

  1. Infliximab and amyloidosis secondary to inflammatory bowel diseases [5] (multiple letters)

    Medicina Clinica, Vol. 124, Núm. 19, pp. 757-758